Previously, we showed that a whole EBOV vaccine based on a replication-defective EBOV (EBOVΔVP30) protects immunized mice and guinea pigs against lethal challenge with rodent-adapted EBOV.
edit: to be clear, k_sze is not wrong, they tested the vaccine against active virus.
http://www.sciencemag.org/content/early/2015/03/25/science.a...
Previously, we showed that a whole EBOV vaccine based on a replication-defective EBOV (EBOVΔVP30) protects immunized mice and guinea pigs against lethal challenge with rodent-adapted EBOV.
edit: to be clear, k_sze is not wrong, they tested the vaccine against active virus.